Several authors have documented that DKK1 was preferential expressed in hormone-resistant breast tumors that was associated with poor prognosis [18] and had identified DKK1 as a serologic and prognostic biomarker for lung and esophageal carcinomas [19]. Here, DKK1 is linked to breast neoplasm.